4 ms·
If the other players in the pharmaceutical supply weren't pushing regulatory capture, blind deals, collusion, and every other trick to keep ricing under their o
by zentiggr 7y ago
If the other players in the pharmaceutical supply weren't pushing regulatory capture, blind deals, collusion, and every other trick to keep ricing under their own control instead of by actual market forces, maybe this would work.
- darkerside 7y agoWhat are blind deals? Collusion seems unlikely between two parties. It's simply unnecessary. Adding a third competitor seems like it would resolve things.
- zentiggr 7y agoPharmacy benefit managers are middlemen who often dictate which drugs are available to a plan, and have been implicated in pushing more expensive alternative drugs in collusion with manufacturers desires to push certain lines for profit. They are also basically under the radar in the stream of third party companies 'providing benefits'.